Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Cambridge Temperature Concepts Announces New CEO Claire Hooper

Published: Monday, December 23, 2013
Last Updated: Sunday, December 22, 2013
Bookmark and Share
Internationally experienced executive joins innovative fertility venture to scale-up its operations.

Cambridge Temperature Concepts (CTC) has announced the appointment of Dr. Claire Hooper as Chief Executive Officer and a member of the Board of Directors, effective 9 December 2013.

Dr. Hooper brings global technology experience to this innovative telemedicine company and has a strong track record in developing and commercializing cutting-edge technologies internationally through partnership and M&A deals.

She brings more than 20 years of relevant industry experience, having previously served as technology director in PerkinElmer and Cambridge Imaging.

Sherry Coutu CBE, CTC’s Co-Chair, investor and serial entrepreneur, welcomes Dr. Hooper’s experience and leadership. She says: “In her new role as chief executive Claire will be responsible for delivering against an ambitious 2014 plan which focuses on rolling out our DuoFertility products in the US and developing the CTC platform within other related healthcare areas. Her results-oriented approach and ability to think strategically will provide the leadership and experience to help us grow.”

DuoFertility accurately predicts ovulation, optimizing a woman’s chances of successful conception. This proven application of telemedicine, based on the latest advances in wireless sensing technology, has created a platform that can be used to deliver other types of remote monitoring.

With Dr Hooper’s appointment, CTC Founder Dr. Shamus Husheer will take the role of Chief Technology Officer. Dr. Husheer says, “We are delighted that Dr. Hooper has agreed to take the commercial lead. She has the experience to drive the business forward and exploit effectively the significant market opportunities that lie ahead.”

Dr. Hooper says that telemedicine is a major opportunity: “CTC founders have put the company at the forefront of this expanding market. I am excited at the prospect of building on this and fully exploiting the opportunities in telemedicine, big data and digital health.”

Life sciences entrepreneur and investor, Dr. Andy Richards, Co-Chair at CTC, says that prior to appointment Claire had been an adviser and played an impressive role in leading and working with the CTC team.

“Claire has considerable experience of scaling healthtech operations. One of her objectives will be to commercialize the CTC platform and expand its use into other important medical areas where m-Health can make a real difference to patients.”

Dr. Hooper has a PhD in biochemistry and also serves as a non-executive director on the board of Abcodia Limited.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More Than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Stem Cells in Drug Discovery
Potential Source of Unlimited Human Test Cells, but Roadblocks Remain.
Automated Low Volume Dispensing Trends
Gain a better understanding of the current and future market requirements for fully automated LVD systems.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Improved Stability, Shelf Life of Protein Drugs
Study improves protein drug stability and extend their shelf life by tested a novel route for non-covalent protein modification.
Plant Analysis – Identifying Metabolites
New plant analysis method shows biologically active plant substances are far more common than previously thought.
New Mechanism to Control Human Viral Infections Discovered
Researchers discover long sought after mechanism in human cells that could help treat diseases caused by viruses.
Biological Link between the Gut Microbiome and Parkinson’s Disease
The findings suggest that targeting the gut microbiome may provide a new approach for diagnosing and treating Parkinson’s disease.
Immune-Cell Traps May Aid Cancer Metastasis
Study suggests cancer cells can induce neutrophils to release traps which the cells use to capture pathogens.
Exploring the Genome of the River Blindness Parasite
Researchers have decoded the genome of the parasite that causes the skin and eye infection known as river blindness.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!